Ophthalmology
Medical history, ocular examination, iris anatomy, pigmentation, corneal health and other relevant findings are considered before an individualized treatment plan is created.
ABOUT MYLUMINEYES®
A Clinical Idea That Became a Focused Ophthalmic Center.
MyLumineyes® is a physician-led ophthalmic center focused on iris pigmentation, laser eye color change, individualized clinical assessment, ophthalmic monitoring and continuing research.
QUICK ANSWER
MyLumineyes® is a specialized ophthalmic center
developed around the clinical work of ophthalmologist
Dr. Mustafa Mete. Its work brings together
ophthalmic assessment, iris pigmentation analysis, staged
laser treatment, clinical monitoring, long-term observation
and research into laser-based iris depigmentation.
01 / MEDICINE
Physician Led
Clinical assessment remains central to treatment decisions.
02 / FOCUS
Iris Pigmentation
A highly focused field rather than a broad cosmetic service menu.
03 / TECHNOLOGY
Laser–Tissue Interaction
Technology is used within an ophthalmic clinical framework.
04 / RESEARCH
Longitudinal Observation
Clinical experience is documented together with its limitations.
01 — THE ORIGIN
It began with the iris, not with a cosmetic trend.
The idea behind Lumineyes developed from a clinical interest in iris pigmentation, melanin and the interaction between ophthalmic laser energy and pigmented tissue.
The central question was not simply whether an eye could appear lighter. It was whether visible iris pigmentation could be approached progressively within an ophthalmic framework that respected anatomy, biological variability, clinical monitoring and long-term observation.
“The objective was never simply a new eye color. The challenge
was to understand how pigment, anatomy, laser energy and biological
response could be approached as one clinical problem.”
02 — DEVELOPMENT
From an early idea to a structured clinical framework.
The history of Lumineyes spans different stages of exploration, technical development and clinical application. These stages should not be treated as interchangeable: an early concept is not the same as a defined clinical protocol, and clinical experience is not the same as independently validated evidence.
2002
Early exploration
The earliest personal exploration of the relationship between iris pigmentation, visible eye color and the possibility of controlled pigment modification began during this period.
2009
Conceptual and technical development
The conceptual and technical development that would later form the Lumineyes approach began to take a more defined form, integrating ophthalmic experience with laser–pigment interaction.
2017
Structured clinical application
The period represented in the current structured clinical dataset begins, with systematic clinical application, documentation and longitudinal observation.
TODAY
Clinical care, technology and research
MyLumineyes continues to develop its clinical framework through individualized ophthalmic assessment, treatment monitoring, longitudinal observation and ongoing scientific documentation.
HISTORICAL RECORD
The Lumineyes Story
This historical video documents an earlier period in the development of the Lumineyes approach. It is presented as part of the historical record rather than as a substitute for current clinical documentation or scientific evidence.
Explore the documented history →
03 — MYLUMINEYES TODAY
One center. Three connected disciplines.
The present MyLumineyes framework sits at the intersection of clinical ophthalmology, laser technology and structured clinical research.
Laser Science
Laser technology is applied within a staged clinical framework. Device capability does not replace physician judgment, patient selection or ophthalmic monitoring.
Clinical Documentation
Longitudinal observations are documented and interpreted according to the type and limitations of the available evidence rather than presented as universal proof.
04 — TECHNOLOGY
Technology supports clinical judgment.
The Lumineyes technology framework has evolved alongside clinical experience in iris imaging, pigmentation assessment, laser–tissue interaction and response-guided treatment planning.
Technology is not presented as a substitute for medical judgment. Its role is to support controlled application, documentation and individualized clinical decision-making.
05 — CLINICAL PHILOSOPHY
Measure. Treat progressively. Observe. Reassess.
01
Assess
Establish the ophthalmic baseline and determine individual suitability before treatment.
02
Individualize
Treatment planning reflects iris characteristics and the complete clinical picture rather than eye color alone.
03
Observe
The eye's clinical and visible response is evaluated progressively rather than assumed in advance.
04
Reassess
Subsequent clinical decisions are adjusted when findings or biological response indicate that they should be.
06 — THE PHYSICIAN
The clinical work behind MyLumineyes.
Dr. Mustafa Mete is an ophthalmologist and clinical researcher whose work includes iris pigmentation, laser iris depigmentation, ophthalmic assessment, treatment monitoring and long-term clinical observation.
His broader clinical background extends across more than 25 years in ophthalmology. The development of the Lumineyes approach represents a focused part of that wider clinical experience.
Clinical field
Ophthalmology
Research identity
ORCID Verified
07 — CLINICAL BOUNDARIES
What defines MyLumineyes — and what does not.
A specialized medical identity is defined as much by its boundaries as by the procedures it performs.
WE DO
01
Perform individualized ophthalmic assessment.
02
Plan treatment according to the individual eye.
03
Document clinical findings and treatment response.
04
Maintain ophthalmic monitoring and follow-up.
05
State the limitations of our clinical evidence.
WE DO NOT
01
Promise an exact final eye color.
02
Determine session count from eye color alone.
03
Treat every applicant regardless of suitability.
04
Present simulations as predictions or guarantees.
05
Present observational experience as independent proof.
08 — RESEARCH & EVIDENCE
Clinical experience and scientific evidence are related — but not identical.
MyLumineyes maintains a clinical and scientific archive covering iris pigmentation, laser–tissue interaction, clinical outcomes, safety monitoring, biological response and longitudinal observation.
Research records are identified according to their evidentiary context. Clinical observation, scientific analysis and independent validation should not be presented as if they carry the same evidentiary weight.
Explore Research →
01 / PRIMARY SOURCE
Clinical documentation remains identifiable.
02 / EVIDENCE STATUS
Research type is distinguished from peer-review status.
03 / LIMITATIONS
Uncertainty and methodological limitations remain visible.
04 / FUTURE WORK
Independent prospective validation remains important.
MYLUMINEYES®
A focused ophthalmic center built around the iris.
Explore the clinical method, meet the physician behind its development, or examine the research and documentation that support the current MyLumineyes framework.
